Charles‐Édouard Luyt

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang, Paul Bastard, Zhiyong Liu et al. · Science · 2020 · 2.4K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

Lila Bouadma, Charles‐Édouard Luyt, Florence Tubach et al. · The Lancet · 2010 · 1.2K citations

Medicine, Pharmacology, Antimicrobial Stewardship +10

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin, Alexis Mathian, Makoto Miyara et al. · Science Translational Medicine · 2020 · 1.1K citations · Full text

Life Sciences, Immunology, Infectious Diseases +9

Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock*

Alain Combes, Pascal Leprince, Charles‐Édouard Luyt et al. · Critical Care Medicine · 2008 · 640 citations

Medicine, Cardiology, Cardiothoracic Surgery +9